Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | MAS | IVZ |
|---|---|---|
| Price | $67.72 | $30.23 |
| Change today | ▲ 0.47% | ▲ 0.23% |
| Market cap | $13.35B | $13.35B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | 15.6 | -44.5 |
| P/B | -36.6 | 1.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.86% | 2.80% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +19.7% | +15.0% |
| Analyst buy share | 29% | 36% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.